VELA Investment Management LLC Has $2.26 Million Stock Holdings in Indivior PLC (NASDAQ:INDV)

VELA Investment Management LLC increased its position in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 45.5% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 179,659 shares of the company's stock after purchasing an additional 56,224 shares during the quarter. VELA Investment Management LLC owned approximately 0.13% of Indivior worth $2,264,000 as of its most recent filing with the SEC.

A number of other institutional investors have also bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. acquired a new position in Indivior during the 4th quarter worth $56,000. Stifel Financial Corp purchased a new stake in shares of Indivior during the 3rd quarter worth $100,000. Melqart Asset Management UK Ltd acquired a new position in shares of Indivior during the 3rd quarter worth $132,000. Jane Street Group LLC purchased a new stake in shares of Indivior in the third quarter valued at $180,000. Finally, Public Employees Retirement System of Ohio acquired a new position in Indivior in the 3rd quarter valued at $294,000. 60.33% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on INDV shares. RODMAN&RENSHAW upgraded Indivior to a "strong-buy" rating in a report on Tuesday, January 28th. Rodman & Renshaw began coverage on Indivior in a research note on Tuesday, January 28th. They set a "buy" rating and a $16.00 price objective for the company.

Remove Ads

Indivior Stock Performance

Shares of INDV stock traded up $0.53 during trading on Tuesday, hitting $10.08. 1,757,143 shares of the company were exchanged, compared to its average volume of 563,999. The firm has a market capitalization of $1.39 billion, a price-to-earnings ratio of -28.73 and a beta of 0.73. Indivior PLC has a twelve month low of $7.33 and a twelve month high of $22.53. The business's 50-day simple moving average is $11.09 and its 200 day simple moving average is $10.65.

Indivior (NASDAQ:INDV - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.32 earnings per share for the quarter, meeting analysts' consensus estimates of $0.32. Indivior had a negative net margin of 3.96% and a negative return on equity of 241.73%. The business had revenue of $298.00 million for the quarter, compared to the consensus estimate of $262.35 million. On average, equities analysts forecast that Indivior PLC will post 1.22 earnings per share for the current fiscal year.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.